Fairvalue-Calculator Fairvalue-Calculator
EN DE

Shaanxi Panlong Pharmaceutical Group (002864) Fair Value & Analysis

Healthcare · CN · Market cap 2.9B CNY

Price¥26.55
Fair Value¥24.54
Upside-7.6%
Quality95/100
Evidence: High Range ¥17.02 – ¥29.03

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Shaanxi Panlong Pharmaceutical Group (002864) currently trades at ¥26.55, while our model-based Fair Value estimate is ¥24.54 — implying the stock looks roughly 7.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was formerly known as Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd and changed its name to Shaanxi Panlong Pharmaceutical Group Co., Ltd. in May 2026. Shaanxi Panlong Pharmaceutical Group Co., Ltd. was founded in 1997 and is based in Xi'an, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Shaanxi Panlong Pharmaceutical Group (002864) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥24.54 versus a price of ¥26.55 — about −8% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 002864?
Our 21-model fair value for Shaanxi Panlong Pharmaceutical Group is ¥24.54 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥26.55.
What is the quality score of 002864?
Shaanxi Panlong Pharmaceutical Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.